-
Bone marrow breakout lesions act as key sites for tumor-immune cell diversification and exhaustion in multiple myeloma
Study
EGAS50000000304
-
Molecular correlates for HPV-negative head and neck cancer engraftment prognosticate patient outcomes
Study
EGAS50000000714
-
Molecular biomarkers in progression from refractory celiac disease to the lethal cancer variety enteropathy associated T cell lymphoma (EATL)
Study
EGAS00001006669
-
Patient-derived models of primary breast cancer for preclinical development of novel neoadjuvant therapies
Study
EGAS50000000398
-
WES IDC samples
Dataset
EGAD50000001148
-
PanelSeq IDC samples
Dataset
EGAD50000001149
-
Count Me In (CMI): The Metastatic Breast Cancer (MBC) Project (CMI-MBCproject)
Study
phs001709
-
Exome Recapture and Sequencing of Prospectively Characterized Clinical Specimens From Cancer Patients
Study
phs001783
-
Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
Study
phs003845
-
Childhood Cancer Data Initiative (CCDI): Pediatric In Vivo Testing Program - Neuroblastoma
Study
phs003163
-
Women's Health Initiative Clinical Trial and Observational Study - Imaging
Study
phs003824
-
Molecular counting enables accurate and precise quantification of methylated ctDNA for tumor-naive cancer therapy response monitoring
Study
EGAS50000000734
-
Matched_breast_cancer_fusion_gene_study
Study
EGAS00001000031
-
MIBC NAC2020 cohort RNA sequencing
Study
EGAS50000000741
-
Single-Cell ATAC and RNA Sequencing of Human Breast Cancer Reveals Salient Cancer-Specific Enhancers
Study
phs003253
-
Transcriptome-Wide Association Study (TWAS) to Identify Susceptibility Genes for Colorectal Cancer
Study
phs002813
-
TIGER-LC High-Throughput Sequencing
Study
phs001199
-
CALGB 40601: Randomized Phase III Trial of Paclitaxel Combined With Trastuzumab, Lapatinib, or Both As Neoadjuvant Treatment of HER2-Positive Primary Breast Cancer
Study
phs001570
-
A Clone's Genomic Stability as a Biomarker of Its DNA-Damage Resilience
Study
phs003762
-
Multi-Modal Single-Cell, Spatial, and Genomic Analyses of Human Non-Small Cell Lung Cancer Brain Metastases
Study
phs003865
-
Metabolic Biomarkers in Thoracic Cancers
Study
phs003880
-
National Cancer Institute Multi-Ancestry Genome-Wide Association Study of Kidney Cancer (NCI-3)
Study
phs003505
-
A Personalized Neoantigen Vaccine Generates Anti-Tumor Immunity in High-Risk Renal Cell Carcinoma
Study
phs003710
-
NRG-GY017: Atezolizumab before and/or with Chemoradiotherapy in Immune System Activation in Patients with Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer
Study
phs003833
-
Results of RNA sequencing from all patients/samples
Dataset
EGAD50000000017
-
Gene Expression Signature in Normal Mammary Gland from 83 Breast Cancer Patients Indicates Pre-tumorous Changes and Adverse Outcomes
Study
EGAS50000000011
-
Dataset RNA sequencing data of tumors from 85 patients with advanced or metastatic cancer treated with radio-immunotherapy
Dataset
EGAD50000000958
-
single cell data from HPV-positive head and neck cancer patients receiving induction CTLA-4 and PD-1 immune checkpoint blockade
Dataset
EGAD50000000487
-
HPV-associated Cancer Consortium Data Access Committee
Dac
EGAC50000000088
-
Spatial Transcriptomics of Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery
Study
phs003862
-
MP2PRT: Genomic and Molecular Characterization of Biomarkers Associated with Tumor Angiogenesis, DNA Repair, and Immunologic Tolerance using Samples from the NRG Oncology Phase 3 Randomized Trial, GOG-0240 (NCT00803062)
Study
phs002293
-
Precision Interception of Gastric Cancer Precursors Through Molecular and Cellular Risk Stratification
Study
phs003648
-
Germline Genetics of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)
Study
phs002962
-
Longitudinal evaluation of circulating tumor DNA in early breast cancer receiving neoadjuvant systemic therapy using a tumor-informed assay
Study
EGAS50000000771
-
Surgery in combination with immune checkpoint therapy as an effective treatment for patients with metastatic cancer.
Study
EGAS00001005667
-
WGS data of 100 Breast Cancer patients from SV Based ctDNA Detection study
Dataset
EGAD50000001175
-
Whole genome sequencing to identify structural variants in early-stage breast cancer
Dac
EGAC50000000461
-
Characterization of alternative promoter usage in advanced prostate cancer
Study
EGAS00001006275
-
Young Boost Trial for Breast Cancer patients
Study
EGAS50000000797
-
Young-Boost Whole Exome Sequencing (WES)
Dataset
EGAD50000001171
-
California Teachers Study (CTS): Whole Genome Sequences From Under-Represented Populations
Study
phs002918
-
Cancer-Restricted Cryptic Antigens Are Targets for T Cell Recognition
Study
phs003887
-
Understanding Determinants of Racial Disparities in Lung Cancer Incidence
Study
phs003789
-
Prediction of Resistance and Sensitivity to HER2 Targeted Therapy in the Neoadjuvant Setting
Study
phs003275
-
Acetalax and bisacodyl triple-negative breast cancer RNA-Seq
Study
EGAS50000000618
-
RNA-seq of CRC patient-derived xenograft tumors
Study
EGAS50000000598
-
Oncogenic FOXL2C134W has gain-of-function chromatin remodeling activity that reprograms glucocorticoid receptor occupancy to promote ovarian granulosa cell tumor growth
Study
EGAS50000000622
-
Whole-exome sequencing profiling of patients with metastatic prostate cancer at VHIO
Study
EGAS50000000736
-
SAPCS 20 Blood RNA-seq from Prostate cancer patients.
Dataset
EGAD50000000982
-
Genetic Studies of Homologous Recombination Deficiency in Hispanic Gastric Cancer
Study
phs003251